Latest in Zepbound Mounjaro

Sort by

6 items

Lilly’s Mounjaro, Zepbound drugs see strong demand. So why did sales disappoint?

Eli Lilly’s stock heads for biggest selloff in more than three years after sales of anti-obesity drugs Mounjaro and Zepbound came up well short of forecasts.
Business - MarketWatch - October 30
Eli Lilly's Zepbound and Mounjaro are no longer in shortage. Here's where their sales still disappointed

Eli Lilly blamed the misses on drug wholesalers cutting inventory of Zepbound and Mounjaro.
Business - CNBC - October 30

Lilly’s Mounjaro, Zepbound drugs see strong demand. So why did sales disappoint?